Moreover, previous studies demonstrated that in bladder cancer, HER2 overexpression strongly correlated with tumour progression and poor prognosis and, unlike BC, HER2 genomic amplification is not a common mechanism [80, 81]. Here, ERBB2 is linked to neoplasm.